Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP0077983A1
公开(公告)日:1983-05-04
New triazine derivatives represented by the formula:
wherein
R1 is aryl, pyridyl, thienyl, 1,2,3,4-tetrahydroquinolyl or 1,3,4,5-tetrahydro-2H-1-benzazepinyl, optionally substituted with lower alkyl, lower alkoxy, halogen, nitro or oxo;
R2 is hydrogen, lower alkyl or carbamoyl substituted with lower alkyl or ar(lower)alkyl; and
Z is a group selected from
and pharmaceutically acceptable salt thereof, processes for preparation thereof and pharmaceutical compositions comprising the same.
由以下式子表示的新型三嗪衍生物
其中
R1 是芳基、吡啶基、噻吩基、1,2,3,4-四氢喹喔啉基或 1,3,4,5-四氢-2H-1-苯并氮杂卓基,可选择被低级烷基、低级烷氧基、卤素、硝基或氧代取代;
R2 是氢、低级烷基或被低级烷基或芳基(低级)烷基取代的氨基甲酰基;以及
Z 是选自以下的基团
及其药学上可接受的盐、制备工艺和包含这些物质的药物组合物。